Clinical Trial Update: Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 study evaluating liposomal doxorubicin (Doxil) in combination with rituximab, cyclophosphamide, vincristine and prednisone for newly diagnosed aggressiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Deltasone (prednisone)
• Doxil (liposomal doxorubicin)
• Oncovin (vincristine)
• Rituxan (rituximab)

Snippet

Sponsor: University of Southern California | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-08-10